Christopher Kirk
2019
In 2019, Christopher Kirk earned a total compensation of $1.9M as President and Chief Scientific Officer at Kezar Life Sciences, a 102% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,800 |
|---|---|
| Option Awards | $1,405,740 |
| Salary | $410,000 |
| Other | $11,794 |
| Total | $1,942,334 |
Kirk received $1.4M in option awards, accounting for 72% of the total pay in 2019.
Kirk also received $114.8K in non-equity incentive plan, $410K in salary and $11.8K in other compensation.
Rankings
In 2019, Christopher Kirk's compensation ranked 6,087th out of 13,971 executives tracked by ExecPay. In other words, Kirk earned more than 56.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,087 out of 13,971 | 56th |
Division Manufacturing | 2,286 out of 5,701 | 60th |
Major group Chemicals And Allied Products | 828 out of 2,200 | 62nd |
Industry group Drugs | 698 out of 1,886 | 63rd |
Industry Pharmaceutical Preparations | 514 out of 1,398 | 63rd |
Source: SEC filing on April 29, 2020.
Kirk's colleagues
We found three more compensation records of executives who worked with Christopher Kirk at Kezar Life Sciences in 2019.